Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LL-10 injection for postoperative analgesia (phase II, randomized, double-blind active-controlled)
CTR20254698Phase 2Completed
- Sponsor
- Shandong New Era Pharmaceutical
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of LL-10 in postoperative pain, sponsored by Shandong New Era Pharmaceutical. Started Dec 2025; status: completed.
02
Drugs
LL-10
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20254698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254698.